(S)-(+)-1-Aminoindan Hydrochloridis CAS 32457-23-1 Puritas >98.0% (HPLC) Imago Featured

(S)-(+)-1-Aminoindan Hydrochloride CAS 32457-23-1 Puritas >98.0% (HPLC)

Description:

Nomen chemicum: (S)-(+)-1-Aminoindan Hydrochloride

CAS: 32457-23-1

Puritas: >98.0% (HPLC)

Aspectus: Alba ad Yellow Firmus

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co, Ltd. est primarium fabricae et elit (S)-(+)-1-Aminoindan hydrochloridis (CAS: 32457-23-1) cum qualitate alta.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	(S)-(+)-1-Aminoindan Hydrochloride
Synonyma	(S)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride;(S) -1-Aminoindane hydrochloride;Rasagiline Medium;(S)-(+)-1-Aminoindan HCl;(S)-2,3-Dihydro-1H-Inden-1-Amine HCl;(S) -1-Indanamine Hydrochloride
CAS Number	32457-23-1
CATTUS Number	RF-CC359
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C9H12ClN
M. Pondus	169.65
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Yellow Firmus
Puritas / Analysis Methodus	>98.0% (HPLC)
Asssay / Analysis Methodo	96.5~ 103.5% (Titration by AgNO3)
Damnum in Siccatio	<1.00%
Totalis immunditias	<2.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

(S)-(+)-1-Aminoindan Hydrochlorideum (CAS: 32457-23-1) medium est Rasagiline (CAS: 136236-51-6) vel Mesylate Rasagiline (CAS: 161735-79-1).Rasagiline Mesylate nova, potens, secundae-generatio, selectiva, immedicabilis MAO-B inhibitor qui ruinam dopaminis impedit.Laudatur in tractatione PD.Indicia rasagilinae usui semel cottidianae sunt sicut monotherapia in primo PD et ut accessio ad levodopam in mediocri ad morbum provectum.Rasagilina signanter emendat symptomata in initio monotherapiae in aegris cum primis PD et quasi adiuncta curatione ad levodopam in aegris modicis provectus.